Letter to the Editor on "Rivaroxaban Use for Thrombosis Prophylaxis is Associated With Early Periprosthetic Joint Infection"

J Arthroplasty. 2016 Sep;31(9):2079. doi: 10.1016/j.arth.2016.05.018. Epub 2016 May 18.

Authors

Adolfo M Llinás¹, Maria P Bautista², Guillermo A Bonilla¹, Meilyn A Muskus², Daniel J Monsalvo²

Affiliations

¹ Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; School of Medicine, Universidad de Los Andes, Bogotá, Colombia; School of Medicine, Universidad del Rosario, Bogotá, Colombia.
² Department of Orthopedics and Traumatology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.

PMID: 27329579
DOI: 10.1016/j.arth.2016.05.018

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Arthritis, Infectious*
Humans
Rivaroxaban*
Thrombosis

Substances

Anticoagulants
Rivaroxaban